Global Veterinary Antibiotics Market to Surpass US$1.93


Seattle, Aug. 10, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the veterinary antibiotics market is estimated at US DOLLARS$ 1.43 bmillion in 2022 and should present a CAGR of 3.8% during the forecast period (2022-2030).

Key trends and analysis of Global Veterinary antibiotics Market:

The major players operating in the market are focusing on adopting growth strategies such as technological advancements and approval of new products, which is expected to drive the growth of the market over the forecast period. For example, in August 2018, Bayer launched i-COWNT BRD, a new online comparison tool designed to help veterinarians make more informed treatment decisions for bovine respiratory disease (BRD). It is based on an independent meta-analysis comparing mixed treatments from BRD treatment studies. I-COWNT BRD simplifies the analysis of scientific data to enable veterinarians to select the most effective antibiotic for treatment.

Request a sample copy of this report @

Main market takeaways:

The global veterinary antibiotics market is expected to show a CAGR of 3.8% during the forecast period due to the advancements in companion animal medicine and surgery, there will be an increasing demand for suitable antibiotics.

Among the product types, the antibacterial segment is expected to hold a dominant position during the forecast period, due to benefits such as preventing and treating animal diseases, protecting public health, and increasing the animal production.

On the basis of end use, the dairy farm segment is expected to hold a dominant position over the forecast period as the use of antibiotics in food producing animals has resulted in healthier animals and more productive; reduced incidence of disease and reduced morbidity and mortality in humans and animals; and the production of large quantities of nutritious, high quality and inexpensive food for human consumption.

Competitive Landscape:

The major players operating in the global veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi SA, Vetoquinol SA, Virbac and Zoetis, Inc.

Buy now this research report @

Market segmentation :

  • Global veterinary antibiotics market, by product type:
    • Anti-parasitic
    • Antibacterial
    • Nonsteroidal anti-inflammatory drug
    • Others
  • Global Veterinary Antibiotics Market, By End Use:
    • Dairy farm
    • Poultry farm
    • Others
  • Global Veterinary Antibiotics Market, by Region:
    • North America
    • Latin America
      • By country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By country
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of Europe
    • Asia Pacific
      • By country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country
        • GCC
        • Israel
        • Rest of the Middle East
    • Africa
      • By region/country
        • South Africa
        • central Africa
        • North Africa

Related Market Information Reports:

Generic Sterile Injectables Marketby drug type (monoclonal antibodies, cytokines, insulin, peptide hormones, vaccines, immunoglobulins, blood factors, antibiotics and others), by therapeutic application (cancer, metabolic diseases, cardiovascular diseases, central nervous system diseases, infectious disorders, musculoskeletal disorders , and others), by distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Size Analysis, Share, Prospects and Opportunities, 2022 – 2030

Acute Bacterial Skin and Skin Structure Infections Marketby drug type (oral and parenteral antibiotics {vancomycin, linezolid, clindamycin, ceftaroline, daptomycin, dalbavancin, tedizolid, and others (rifampicin, doxycycline, minocycline, and trimethoprim-sulfamethoxazole, among others)}), and topical antibiotics {hydrogen peroxide , fusidic acid, mupirocin, retapamulin and povidone-iodine}), by type of infection (ABSSSI of hospital origin and ABSSSI of community origin), by route of administration (oral, parenteral and topical), by distribution channel (hospital pharmacies, retail pharmacies and online pharmacies), and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Size, Share, Prospects and opportunities, 2022 – 2030

About Us:

Consistent market information is a global market intelligence and advisory organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is in India, with a sales office in the world’s financial capital in the USA and sales advisors in the UK and Japan. Our client base includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Follow us: LinkedIn | Twitter


About Author

Comments are closed.